162 related articles for article (PubMed ID: 22476540)
1. Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.
Hunsawong T; Singsuksawat E; In-chon N; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-in S; Thuwajit P
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1311-20. PubMed ID: 22476540
[TBL] [Abstract][Full Text] [Related]
2. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
[TBL] [Abstract][Full Text] [Related]
3. The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.
Kaewlert W; Sakonsinsiri C; Namwat N; Sawanyawisuth K; Ungarreevittaya P; Khuntikeo N; Armartmuntree N; Thanan R
Horm Cancer; 2018 Dec; 9(6):408-419. PubMed ID: 30284180
[TBL] [Abstract][Full Text] [Related]
4. High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K.
Treekitkarnmongkol W; Suthiphongchai T
World J Gastroenterol; 2010 Aug; 16(32):4047-54. PubMed ID: 20731018
[TBL] [Abstract][Full Text] [Related]
5. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.
Mancino A; Mancino MG; Glaser SS; Alpini G; Bolognese A; Izzo L; Francis H; Onori P; Franchitto A; Ginanni-Corradini S; Gaudio E; Alvaro D
Dig Liver Dis; 2009 Feb; 41(2):156-63. PubMed ID: 18395502
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
[TBL] [Abstract][Full Text] [Related]
7. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
8. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.
Pongcharoen P; Jinawath A; Tohtong R
Clin Exp Metastasis; 2011 Dec; 28(8):827-39. PubMed ID: 21833756
[TBL] [Abstract][Full Text] [Related]
10. Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma.
Juntavee A; Sripa B; Pugkhem A; Khuntikeo N; Wongkham S
World J Gastroenterol; 2005 Jan; 11(2):249-54. PubMed ID: 15633225
[TBL] [Abstract][Full Text] [Related]
11. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma.
Ishida H; Wada K; Masuda T; Okura M; Kohama K; Sano Y; Nakajima A; Kogo M; Kamisaki Y
Cancer Sci; 2007 May; 98(5):636-43. PubMed ID: 17355262
[TBL] [Abstract][Full Text] [Related]
12. The trefoil factor 1 (TFF1) protein involved in doxorubicin‑induced apoptosis resistance is upregulated by estrogen in breast cancer cells.
Pelden S; Insawang T; Thuwajit C; Thuwajit P
Oncol Rep; 2013 Sep; 30(3):1518-26. PubMed ID: 23836323
[TBL] [Abstract][Full Text] [Related]
13. ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.
Fan J; Yin WJ; Lu JS; Wang L; Wu J; Wu FY; Di GH; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2008 Aug; 134(8):883-90. PubMed ID: 18264725
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
[TBL] [Abstract][Full Text] [Related]
16. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.
Ma B; Meng H; Tian Y; Wang Y; Song T; Zhang T; Wu Q; Cui Y; Li H; Zhang W; Li Q
BMC Cancer; 2020 Apr; 20(1):318. PubMed ID: 32293336
[TBL] [Abstract][Full Text] [Related]
18. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
20. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
